Leading Author and Director of Pre-Clinical Services at the North Texas Health Science Center, William Weiss, to present on antimicrobial therapy this fall

LONDON, ENGLAND, UNITED KINGDOM, October 11, 2016 /EINPresswire.com/ -- SMi Group are delighted to have William Weiss, Leading Author and Director of Pre-Clinical Services at the North Texas Health Science Center (UNTHSC), present an exclusive keynote address on antimicrobial therapy at Superbugs & Superdrugs USA this fall.

The congress, set to take place on Nov 14th and 15th in Iselin, New Jersey, has attracted an audience of high level industry leaders and government bodies following a recent United Nations General Assembly on antimicrobial resistance (AMR).

An attendee list is available in the event download centre.

As well as presenting on antimicrobial combination therapy, Dr Weiss will also be leading a pre-conference interactive workshop taking place on Nov 16th.

With a focus on the use of animal models in pre-clinical drug development, the session will provide attendees with an in-depth discussion on the transition from vitro activity to in vivo efficacy, explore animal model choices for proof of concept studies, and provide examples of relevant animal models with supportive data and interpretation of results as it relates to the clinical condition.

Dr Bill Weiss has over 33 years of experience in infectious disease research and has worked on numerous antibacterial programs leading the discovery and development of new antimicrobial agents.
His expertise encompasses the development and evaluation of animal models of infectious disease as well as pharmacokinetic and pharmacodynamic analysis.

Other notable speakers on the Superbugs USA agenda include:

• Dr Pilar Ramon-Pardo, Advisor on Clinical Management of Infectious Diseases and Antimicrobial Resistance, PAHO/WHO
• Dr John Rex, Senior Vice President and Chief Strategy Officer, Infection Business Unit, Astra Zeneca
• Dr Christopher Houchens, Branch Chief, Antibacterials Program, BARDA
• Dr Rosemarie Aurigemma, Chief, Biodefense Drug Development Section, DMID, NIAID, NIH
• Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer
• Dr Anthony Simon Lynch, Senior Scientific Director, Janssen Research & Development LLC
• Dr Mahesh Kumar, Vice President, Global Biological Research and Development, Zoetis

The full speaker line-up and conference agenda is available online at www.superbugs-usa.com

Superbugs & Superdrugs USA
The Global Attack Against Bacteria's Defensive Walls
November 14th & 15th 2016
Renaissance Woodbridge Hotel, Iselin, New Jersey
Sponsored by Noigel, LLC and Polyphor
http://www.superbugs-usa.com

Contact Information:
For all media enquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk
To register for the conference, visit http://www.superbugs-usa.com or contact Matthew Apps on Tel: +44 (0)20 7827 6093 / Email: mapps@smi-online.co.uk
To sponsor, speak or exhibit at the conference, contact Alia Malick on Tel: +44 (0)20 7827 6168 / Email: amalick@smi-online.co.uk

---END---

About SMi Group:

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Teri Arri
SMi Group
2078276000
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.